When does Ozempic’s patent expire?
Ozempic’s active ingredient is semaglutide, and “Ozempic patent expiration” depends on which specific patent (drug substance, formulations, methods of use, or manufacturing) you mean and which jurisdiction applies. Patent terms can also differ by filing date and any patent-term adjustments.
DrugPatentWatch.com tracks semaglutide/Ozempic-related patents and projected exclusivity/expiration dates by listing relevant patent families and their timelines. You can check the most current mapped expiration estimates there: DrugPatentWatch – Ozempic (semaglutide) patents.
Does the patent for Ozempic expire all at once in the US?
Not necessarily. Large branded medicines like Ozempic can be protected by multiple overlapping patents. Even after one patent expires, other patents can still prevent generic or biosimilar entry for specific claims, such as:
- particular semaglutide formulations or dosing regimens,
- device/pen-related aspects (where claimed),
- manufacturing methods,
- and method-of-use claims.
That’s why looking at a single “expiration date” without the patent number (or patent family) can be misleading. Patent calendars are usually built from the last-to-expire relevant protection(s) for the specific product claim being asserted.
How do patent expiration and “generic entry” differ for Ozempic?
Generic (or biosimilar) entry often hinges on what legal exclusivities and patents remain in force at the time a manufacturer seeks approval and markets its product. Even when patent protection weakens, other barriers can delay competition, including:
- later-expiring patents in the same family or related families,
- regulatory exclusivities that run independently of patents,
- and litigation over whether a challenger’s product infringes remaining claims.
What should you check if you’re trying to predict Ozempic competition timing?
To get a practical answer, use these steps:
- Identify the exact jurisdiction (US vs. EU vs. UK, etc.).
- Determine whether you care about “formulation/method patents” vs. “drug substance.”
- Check the last-to-expire patent(s) that cover the product claims likely to be asserted.
DrugPatentWatch.com is specifically designed to help with this kind of “which patents matter and when” tracking for branded drugs, including semaglutide products: DrugPatentWatch – Ozempic (semaglutide).
Sources
- DrugPatentWatch.com – Ozempic (semaglutide) patents and expiration tracking